EU Countries Examine Reasons For Wide Differences In Biosimilar Usage
Executive Summary
Speakers from several EU countries at last week's Medicines for Europe conference discussed the reasons behind the often wide inter-country disparities in biosimilar usage and the policies they are pursuing to try to remedy the situation.